KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 173 filers reported holding KARUNA THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.61 and the average weighting 0.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $7,480,644 | -23.4% | 44,241 | -1.7% | 0.01% | -14.3% |
Q2 2023 | $9,763,236 | -33.7% | 45,023 | -44.6% | 0.01% | -41.7% |
Q1 2023 | $14,731,397 | +5.5% | 81,269 | +14.4% | 0.01% | +9.1% |
Q4 2022 | $13,958,181 | -9.9% | 71,034 | +3.1% | 0.01% | -21.4% |
Q3 2022 | $15,500,000 | +47.9% | 68,913 | -16.8% | 0.01% | +55.6% |
Q2 2022 | $10,483,000 | -36.0% | 82,864 | -35.9% | 0.01% | -18.2% |
Q1 2022 | $16,391,000 | -3.6% | 129,277 | -0.4% | 0.01% | 0.0% |
Q4 2021 | $17,007,000 | +8.9% | 129,823 | +1.7% | 0.01% | 0.0% |
Q3 2021 | $15,618,000 | +7.1% | 127,671 | -0.2% | 0.01% | +10.0% |
Q2 2021 | $14,580,000 | -11.9% | 127,906 | -7.1% | 0.01% | -16.7% |
Q1 2021 | $16,545,000 | +16.0% | 137,611 | -2.0% | 0.01% | +9.1% |
Q4 2020 | $14,261,000 | +39.7% | 140,376 | +6.3% | 0.01% | +22.2% |
Q3 2020 | $10,209,000 | +16.3% | 132,033 | +67.7% | 0.01% | +12.5% |
Q2 2020 | $8,777,000 | – | 78,743 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Pivotal bioVenture Partners Investment Advisor LLC | 782,008 | $169,578,435 | 55.90% |
Nan Fung Group Holdings Ltd | 225,688 | $48,940,443 | 31.28% |
Sofinnova Investments, Inc. | 1,381,149 | $299,502,161 | 19.62% |
Paradigm Biocapital Advisors LP | 283,605 | $61,499,744 | 4.75% |
First Light Asset Management, LLC | 208,746 | $45,266,570 | 3.55% |
Avidity Partners Management LP | 442,200 | $95,891,070 | 3.35% |
CATALYST PRIVATE WEALTH, LLC | 21,837 | $4,735,353 | 2.97% |
Rock Springs Capital Management LP | 493,527 | $107,021,330 | 2.55% |
Boxer Capital, LLC | 250,000 | $54,213 | 2.51% |
DAFNA Capital Management LLC | 42,173 | $9,145,215 | 2.50% |